XML 35 R2.htm IDEA: XBRL DOCUMENT v3.26.1
Consolidated Balance Sheets - USD ($)
Dec. 31, 2025
Dec. 31, 2024
Current Assets:    
Cash and cash equivalents $ 478,983 $ 800,735
Restricted Cash 31,936
Accounts receivables and other receivables, net 2,771,443 5,528,826
Income taxes receivable 257,304 1,657,829
Prepayments 1,660,661 2,269,493
Other current assets 176,044 509,333
Total Current Assets 5,344,435 10,798,152
Non Current Assets:    
Property and equipment, net 444,967 593,357
Intangible assets, net 6,730,155 6,168,534
Investment in Joint Venture 134,475
Total Non Current Assets 7,309,597 6,761,891
Total Assets 12,654,032 17,560,043
Current Liabilities:    
Accounts payable 2,364,291 3,373,487
Vouchers payable 2,897,175 6,477,256
Accrued expenses 2,232,670 3,128,515
Value-added tax payable 233,441 32,387
Other current liabilities 143,073
Shareholder loans payable 8,123,835 50,057,013
Short-term borrowings 3,765,234 558,206
Total Current Liabilities 19,616,646 63,769,937
Non Current Liabilities:    
Convertible Shareholder loans, at fair value 22,560,124
Total Non current Liabilities 22,560,124
Total Liabilities 19,616,646 86,330,061
Commitments and Contingencies (Note 15)
Common stock £0.002 par value; [79,420,315] shares authorized; 55,318,354 and 25,000,043 shares issued and outstanding as of December 31, 2025 and 2024, respectively 137,820 65,280
Additional paid-in capital 183,489,676 74,374,429
Accumulated deficit (194,657,170) (148,420,321)
Accumulated other comprehensive income 4,067,061 5,210,594
Total Stockholders’ Deficit (6,962,613) (68,770,018)
Total Liabilities and Stockholders’ Deficit $ 12,654,033 $ 17,560,043